Robert Lathrop, an accomplished inventor based in Fort Collins, Colorado, has made significant strides in the field of drug delivery systems. With a portfolio of eight patents, he is recognized for his innovative contributions that enhance the effectiveness of topical skin compositions, particularly in the treatment of conditions like psoriasis.

Latest Patents

Among his latest innovations, Robert Lathrop has developed a topical skin composition that delivers drug nanoparticles. This formulation comprises over 50% w/w of a continuous hydrophobic carrier, 5-24% w/w of volatile silicone fluids, and a range of taxane nanoparticles with a mean particle size ranging from 0.1 to 1.5 microns. He has also focused on methods that improve the skin penetration of these drug nanoparticles and inhibit crystal growth in various carriers. His work specifically outlines compositions for enhancing the topical treatment of psoriasis using paclitaxel and other taxanes.

Career Highlights

Throughout his career, Robert has worked with various companies, notably enhancing his expertise at DFB Soria, LLC and Medigene AG. His contributions in these organizations underscore his commitment to innovation in drug delivery technologies.

Collaborations

Lathrop has collaborated with a talented team, including colleagues Keith Johnson and Yunik Chang, to push the boundaries of existing pharmaceutical technologies. Their collective efforts have fostered advancements in the application of drug nanoparticles in clinical settings.

Conclusion

Robert Lathrop's body of work exemplifies dedication to innovation in the pharmaceutical field. His patents not only enhance drug delivery mechanisms but also pave the way for new treatment options for patients. With continued research and collaboration, the future looks promising for his ongoing contributions to medical science.

This text is generated by artificial intelligence and may not be accurate.